HETEROCYCLIC COMPOUND

The present invention provides a compound having a CaMKII inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of cardiac diseases (particularly catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, fatal ar...

Full description

Saved in:
Bibliographic Details
Main Authors OKAMOTO, Rei, MIURA, Joanne, SHIBUYA, Akito, TAKAHASHI, Masashi, SCORAH, Nicholas, KWOK, Lily, TANIS, Paul, KOMANDLA, Mallareddy, TYHONAS, John, SHIOKAWA, Zenyu, TAKAHAGI, Hiroki, OKAWA, Tomohiro, NISHIKAWA, Yoichi, SABAT, Mark, WANG, Haixia, WANG, Xiaolun, NAKAHATA, Takashi, MATSUNAGA, Nobuyuki, MIYAMOTO, Yasufumi, VU, Phong H, SHIRAI, Junya, YOSHIKAWA, Takeshi, TERAO, Yoshito, KAKEGAWA, Keiko, YUKAWA, Takafumi, TAKAGI, Terufumi, TANAKA, Yuta
Format Patent
LanguageEnglish
French
German
Published 28.10.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a compound having a CaMKII inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of cardiac diseases (particularly catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, fatal arrhythmia) and the like.The present invention relates to a compound represented by the formula (I):wherein each symbol is as defined in the specification,or a salt thereof.
Bibliography:Application Number: EP20180777887